Drawing for PRIMESPAN HEALTH

USPTO serial 99772287

PRIMESPAN HEALTH

Reviewed by CopyMark Law Group

Status 681
Filing date
Status date
Registration date
—
Examiner
HETZEL, DANNEAN
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with PRIMESPAN HEALTH?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Baruch Gottesman

11 Broadway, Suite 615New York, NY 10004United States

Goods and services

ClassDescriptionStatusFirst use
005Dietary and nutritional supplements; Nutritional and dietary supplements formed and packaged as bars; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Probiotic supplements; Homeopathic supplements; Mineral supplements; Herbal supplements; Calcium supplements; Vitamin supplements; Food supplements; Dietary supplementsACTIVEJan 1, 2026

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 4, 2026NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Oct 14, 2026CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Oct 13, 2026TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Oct 13, 2026CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 13, 2026ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
Aug 4, 2026GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Aug 4, 2026GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Aug 4, 2026CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jul 30, 2026TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jul 30, 2026CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jul 30, 2026TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 24, 2026GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 24, 2026GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 24, 2026CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 20, 2026DOCKASSIGNED TO EXAMINER—
Apr 18, 2026MAFRAPPLICATION FILING RECEIPT MAILED—
Apr 18, 2026NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Apr 18, 2026NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance